Effects of Impurities on Crystal Polymorphism of an Imidazopyridine Derivative Developed as a Drug Substance for Osteoporosis
スポンサーリンク
概要
- 論文の詳細を見る
A drug substance, (8-(2,6-dichlorobenzoyl-amino)-3-hydroxymethyl-2-trifluoromethylimidazo [1,2-a] pyridine (named BPPI)), developed for osteoporosis treatment, has two crystal polymorphs: an unstable B01-form and a stable B02-form. In the early stage of development, only the B01-form was always obtained from an ethanol/water solution. However, after improvements in purity of BPPI, only the B02-form was obtained. Four major impurities incorporated in the B01-form are identified and 4 analogues of BPPI are separately synthesized. The inhibitory effects on the solvent-mediated transformation of the B01-form to the B02-form are examined to explain the disappearance of the B01-form and the new appearance of the B02-form. As a result, it is found that the dimer of BPPI, which was a by-product of the last reaction of BPPI synthesis, had inhibited nucleation of the B02-form crystals. 0.107 mg/mL of dimer completely inhibited the transformation of the B01-form. The inhibitory effect of the dimer on the nucleation of the B02-form is discussed by focusing on the failure of two intermolecular hydrogen bondings that should be formed in the B02-form crystal.
- 社団法人 化学工学会の論文
- 2009-03-01
著者
-
Ooshima Hiroshi
Department Of Applied Chemistry And Bioengineering Graduate School Of Engineering Osaka City Univers
-
Ooshima Hiroshi
Department Of Applied And Bioapplied Chemistry Graduate School Of Engineering Osaka City University
-
HIRANO Masaru
Department of Applied chemistry and Bioengineering, Graduate School of Engineering, Osaka City Unive
-
Hirano Masaru
Department Of Applied Chemistry And Bioengineering Graduate School Of Engineering Osaka City Univers
-
MACHIYA Koji
Department of Applied Chemistry and Bioengineering, Graduate School of Engineering, Osaka City Unive
-
IEDA Shigeru
Process Chemistry Laboratories, Astellas Pharma Inc.
-
Ieda Shigeru
Process Chemistry Laboratories Astellas Pharma Inc.
-
Machiya Koji
Department Of Applied Chemistry And Bioengineering Graduate School Of Engineering Osaka City Univers
-
Ooshima Hiroshi
Department Of Applied Chemistry And Bioengineering Graduate School Of Engineering Osaka City Univers
関連論文
- Relationship between Crystal Polymorphism and Solution Structure of an Imidazopyridine Derivative Developed as a Drug Substance for Osteoporosis
- Growth mechanism of the calcium carbonate tubes on a cation-exchange membrane( Ceramics for Biomedical Applications in Asian Countries)
- The Effects of Impurities on Crystallization of Polymorphs of a Drug Substance AE1-923
- Synthesis and Degradation of Acyl Peptide Using Enzyme from Pseudomonas aeruginosa(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- Saccharomyces cerevisiae Mutant Displaying β-Glucans on Cell Surface(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
- Purification and Characterization of Enzyme Responsible for N-Myristoylation of Octapeptide in Aqueous Solution without ATP and Coenzyme A from Pseudomonas aeruginosa(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- Relationship between Cell Morphology and Intracellular Potassium Concentration in Candida albicans
- Valinomycin Affects the Morphology of Candida albicans
- Deletion of MCD4 Involved in Glycosylphosphatidylinositol (GPI) Anchor Synthesis Leads to an Increase in β-1,6-Glucan Level and a Decrease in GPI-Anchored Protein and Mannan Levels in the Cell Wall of Saccharomyces cerevisiae(Microbial Physiology and Biot
- Analysis of Chitin at the Hyphal Tip of Candida albicans Using Calcofluor White